Consultant in Haematology | The Christie NHS Foundation Trust
| Dyddiad hysbysebu: | 14 May 2024 |
|---|---|
| Cyflog: | Heb ei nodi |
| Gwybodaeth ychwanegol am y cyflog: | £93,666 - £126,281 Per Annum. This role will also receive a one-off attraction payment of 20% of the first year’s annual salary (pre-tax, NI contributions) on commencement of employment. * |
| Oriau: | Full time |
| Dyddiad cau: | 13 June 2024 |
| Lleoliad: | Manchester, OL6 9RW |
| Cwmni: | The Christie NHS Foundation Trust |
| Math o swydd: | Permanent |
| Cyfeirnod swydd: | 6310461/413-MD-C2023-23367---E |
Crynodeb
An exciting opportunity has arisen to join the Haematology and TYA Directorate, as a 10 PA Consultant Haematologist to provide specialist care for Christie Haematology patients at Tameside and Glossop Integrated Care NHS Foundation Trust.
The post-holder will work alongside the existing team of 14 Consultants based at The Christie main site and will work alongside another Consultant Haematologist, Lead Clinical Nurse Specialist/Operational Lead and Clinical Nurse Specialist.
The successful candidate will be highly motivated and driven to improve patient care and experience. They will be an excellent oral and written communicator and they will use their well-developed clinical and professional leadership skills to encourage and promote best outcomes for patients, their relatives, and their carers. Excellent interpersonal skills are paramount for this post together with confidence to engage and work with a range of colleagues at all levels and from all professional groups.
The successful applicant will be responsible for the management of Haematology patients. There is both inpatient and outpatient management of a wide variety of benign and malignant haematological disorders as would be typical of a District General Hospital haematology practise.
The successful applicant will have access to office accommodation provided within the department and secretarial/PA support.
Haematology has no dedicated inpatient beds, however, they provide a service to the Medical and Surgical Directorates to give haematological assessments when required. This is currently provided by ad-hoc visits as required. Haematology patients receiving out-patient care, including those attending the Tameside Macmillan Unit, that require in-patient treatment remain under the care of the admitting General Physician with the haematologist providing relevant advice. General Physicians also manage patients with venous thromboembolic problems and liaise closely with the anticoagulant service.
There is an out of hours non-resident on call rota currently shared with Stepping Hill Hospital. The Post holder may be asked to participate in this depending on experience.
The Christie is one of Europe’s leading cancer centres, treating over 60,000 patients a year. We are based in Manchester and serve a population of 3.2 million across Greater Manchester & Cheshire, but as a national specialist around 15% patients are referred to us from other parts of the country.
We provide radiotherapy through one of the largest radiotherapy departments in the world; chemotherapy on site and through 14 other hospitals; highly specialist surgery for complex and rare cancer; and a wide range of support and diagnostic services. We are also an international leader in research, with world first breakthroughs for over 100 years.
We run one of the largest early clinical trial units in Europe with over 300 trials every year. Cancer research in Manchester, most of which is undertaken on the Christie site, has been officially ranked the best in the UK.
These posts are part of a collaborative venture between the Christie NHS Foundation Trust (CFT) and Tameside and Glossop Integrated Care NHS Foundation Trust (TGH) to support the development of haematology services across the southern sector of the Greater Manchester and Cheshire Cancer Network (GMCCN) and the delivery of clinical and laboratory haematology on the TGH site. The post will be established at the Christie although the majority of the clinical sessions will be undertaken at TGH. The post holder will be a core member of the Christie leukaemia/myeloma and lymphoma multidisciplinary teams and the post also offers the opportunity to develop a special interest in an area of malignant haematology at the Christie if required to suit the interests of the successful applicant.
The Haematology department based at TGH is run by a highly motivated team providing outpatient, day care and inpatient service to BCSH level 1. At the Christie, the appointment will join the existing team of 14 Consultants and at TGH will complement the current single-handed Haematologist, a Clinical Nurse Specialist/Service Manager and Clinical Nurse Specialist.
The appointee will be expected to participate a shared on-call rota (currently with Stepping Hill Hospital) for out of hours work. There will be no on-call commitment on the Christie Site.
DUTIES AND RESPONSIBILITIES
The medical establishment provides 14 consultants within the department.
The appointees will be based at Tameside and will report to the Clinical Director of Haematology & Teenage and Young Adult Cancer at The Christie NHS Trust with accountability to the Medical Director at The Christie NHS Foundation Trust.
• To develop and implement best practice in Haematology
• To support the existing staff at Tameside in delivery of a high quality service
• To be a core member of the GMCCN Southern Sector Multidisciplinary Team (MDT)
Diagnostic support
Radiology (X ray, MRI and CT scan) and Pharmacy services are available at Tameside.
The Pathology Collaborative
Pathology is provided via Tameside.
Diagnostic samples from haematology patients are handled and reported by the Greater Manchester Haematological Cancer Diagnostic Partnership (HODS).
The Haematology Laboratory Department
The haematology laboratory holds full UKAS accreditation status to ISO 15189:2012. The department is registered in the United Kingdom External Quality Assessments scheme for its full repertoire of tests including coagulation, blood transfusion, full blood counts and other general haematology tests.
Haematology, Biochemistry and Blood Transfusion have been merged to provide a combined blood science service. The laboratory is fully CPA accredited and takes part in all relevant NEQAS schemes.
The services consist of:
• Biochemistry
• Haematology
• Blood Transfusion
• Mortuary and Bereavement Services
• Virology (Screening only for Hepatitis otherwise MMMP)
• Microbiology
• Cellular Pathology (Located at UHSM)
Blood Transfusion
There is a well-established hospital blood transfusion committee and team. The committee meets quarterly and deals with current issues and determines long term strategy. It consists of laboratory, A&E, theatre and ward representatives, plus the Hospital Transfusion Practitioner. The Consultant +/- CNS will be invited to the HTC which is held 3 months per year.
The Hospital Transfusion Team meets monthly, performs regular audits and implements improvement and educational strategies. This has ensured the Trust has successfully maximised the use of blood and blood products.
Clinical Haematology
There is both inpatient and outpatient management of a wide variety of benign and malignant haematological disorders as would be typical of a District General Hospital haematology practise.
Haematology has no dedicated inpatient beds, however, they provide a service to the Medical and Surgical Directorates to give haematological assessments when required. This is currently provided by ad-hoc visits as required. Haematology patients receiving out-patient care, including those attending the Tameside Macmillan Unit, that require in-patient treatment remain under the care of the admitting General Physician with the haematologist providing relevant advice. General Physicians also manage patients with venous thromboembolic problems and liaise closely with the anticoagulant service.
There is considerable liaison with local General Practitioners for haematological advice, both written and by telephone along with clinical advice and guidance via the NHS Electronic Referral Service
Pre-COVID pandemic the clinical haematology department reviewed approximately 46 new haematology outpatients and 220 review patients per month. Day case attendances numbered approximately 85 per month (Monday and Thursday)
The current haematology inpatient and outpatient case mix consists of general haematology, low grade haematological malignancy which includes chronic myeloid and chronic lymphocytic leukaemia, myeloma plus myelodysplasias and a variety of haemostatic and thrombotic problems. Cases of acute leukaemia in younger patients requiring intensive chemotherapy are referred onward to the specialist haematology unit at the Christie Hospital.
The treatment of haematological malignancies is by protocol and is also based on the BCSH and North West Haemato-Oncology guidelines. Chemotherapy is electronically prescribed using the iQemo computerised system.
When appropriate, patients with haemoglobinopathies are referred to the Sickle cell and Thalassaemia Centre at the Central Manchester Hospital. Patients with haemophilia and other congenital bleeding disorders are referred to the Thrombosis and Haemostasis Centre at the Manchester Royal Infirmary.
Out of hours cover and on-call
The appointees will be expected to participate in an out of hours on shared with Stockport NHS Foundation Trust (currently 1:4). It is anticipated that the out of hours arrangements may change going forward to include cover for East Cheshire NHS Trust although at reduced frequency.
This advert closes on Friday 7 Jun 2024
Aelod balch o'r cynllun cyflogwyr Hyderus o ran Anabledd
Hyderus o ran Anabledd
Gwybodaeth am Hyderus o ran Anabledd
Yn gyffredinol, bydd cyflogwr Hyderus o ran Anabledd yn cynnig cyfweliad i unrhyw ymgeisydd sy'n datgan eu bod yn anabl ac yn bodloni'r meini prawf lleiaf ar gyfer y swydd fel y diffinnir gan y cyflogwr. Mae'n bwysig nodi, mewn rhai sefyllfaoedd recriwtio fel nifer fawr o ymgeiswyr, cyfnod tymhorol ac amseroedd prysur iawn, efallai y bydd y cyflogwr am gyfyngu ar y niferoedd cyffredinol o gyfweliadau a gynigir i bobl anabl a phobl nad ydynt yn anabl. Am fwy o fanylion ewch i Hyderus o ran Anabledd.